CliffBio
small molecule

LIDOCAINE AND PRILOCAINE

LIDOCAINE; PRILOCAINE

Loss of exclusivity—loss of exclusivity
CompanyAlembic →See this company's full patent-cliff portfolio

Drug detail

Brand nameLIDOCAINE AND PRILOCAINE
Active ingredientLIDOCAINE; PRILOCAINE
Strength2.5%;2.5%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalApril 2022
Marketing statusRX

More from Alembic

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.